Interestingly, the effect of physapubescin on expression of CHOP and DR5 was only observed in VHL deficient cells with HIF-2α over-expression, but not in VHL wild-type RCC cells that do not have HIF-2α expression. This evidence concerns the gene EPAS1 and renal cell carcinoma.